Dr. Unizony is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Rheumatology Department, Bulfinch 165
Boston, MA 02114Phone+1 617-726-2000Fax+1 617-726-2872
Education & Training
- Massachusetts General HospitalFellowship, Rheumatology, 2009 - 2011
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2006 - 2009
- Universidad Nacional de La Plata Faculty of MedicineClass of 2002
Certifications & Licensure
- MA State Medical License 2011 - 2025
- NH State Medical License 2021 - 2023
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Clinical Trials
- Ustekinumab for the Treatment of Giant Cell Arteritis Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 910 citationsEfficacy of Tocilizumab in Patients Hospitalized with Covid-19.John H. Stone, Matthew J. Frigault, Naomi Serling-Boyd, Ana D. Fernandes, Liam Harvey
The New England Journal of Medicine. 2020-10-21 - 13 citationsChallenging Mimickers of Primary Systemic VasculitisEli M. Miloslavsky, John H. Stone, Sebastian Unizony
Rheumatic Diseases Clinics of North America. 2015-02-01 - 311 citationsTrial of Tocilizumab in Giant-Cell Arteritis.John H Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer
The New England Journal of Medicine. 2017-07-27
Press Mentions
- New Drugs, Treatment Strategies Aim to Lessen Rheumatic Diseases’ Reliance on SteroidsJuly 25th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: